Accessibility Statement Skip Navigation
  • Why PRWeb
  • How It Works
  • Who Uses It
  • Pricing
  • Login
  • GDPR
  • Create a Free Account
Return to PRWeb homepage
  • News
  • Resources
  • Contact
When typing in this field, a list of search results will appear and be automatically updated as you type.

Searching for your content...

No results found. Please change your search terms and try again.
  • News in Focus
      • Browse News Releases

      • All News Releases
      • Multimedia Gallery

      • All Multimedia
      • All Photos
      • All Videos
  • Business & Money
      • Auto & Transportation

      • Aerospace, Defense
      • Air Freight
      • Airlines & Aviation
      • Automotive
      • Maritime & Shipbuilding
      • Railroads and Intermodal Transportation
      • Supply Chain/Logistics
      • Transportation, Trucking & Railroad
      • Travel
      • Trucking and Road Transportation
      • View All Auto & Transportation

      • Business Technology

      • Blockchain
      • Broadcast Tech
      • Computer & Electronics
      • Computer Hardware
      • Computer Software
      • Data Analytics
      • Electronic Commerce
      • Electronic Components
      • Electronic Design Automation
      • Financial Technology
      • High Tech Security
      • Internet Technology
      • Nanotechnology
      • Networks
      • Peripherals
      • Semiconductors
      • View All Business Technology

      • Entertain­ment & Media

      • Advertising
      • Art
      • Books
      • Entertainment
      • Film and Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • View All Entertain­ment & Media

      • Financial Services & Investing

      • Accounting News & Issues
      • Acquisitions, Mergers and Takeovers
      • Banking & Financial Services
      • Bankruptcy
      • Bond & Stock Ratings
      • Conference Call Announcements
      • Contracts
      • Cryptocurrency
      • Dividends
      • Earnings
      • Earnings Forecasts & Projections
      • Financing Agreements
      • Insurance
      • Investments Opinions
      • Joint Ventures
      • Mutual Funds
      • Private Placement
      • Real Estate
      • Restructuring & Recapitalization
      • Sales Reports
      • Shareholder Activism
      • Shareholder Meetings
      • Stock Offering
      • Stock Split
      • Venture Capital
      • View All Financial Services & Investing

      • General Business

      • Awards
      • Commercial Real Estate
      • Corporate Expansion
      • Earnings
      • Environmental, Social and Governance (ESG)
      • Human Resource & Workforce Management
      • Licensing
      • New Products & Services
      • Obituaries
      • Outsourcing Businesses
      • Overseas Real Estate (non-US)
      • Personnel Announcements
      • Real Estate Transactions
      • Residential Real Estate
      • Small Business Services
      • Socially Responsible Investing
      • Surveys, Polls and Research
      • Trade Show News
      • View All General Business

  • Science & Tech
      • Consumer Technology

      • Artificial Intelligence
      • Blockchain
      • Cloud Computing/Internet of Things
      • Computer Electronics
      • Computer Hardware
      • Computer Software
      • Consumer Electronics
      • Cryptocurrency
      • Data Analytics
      • Electronic Commerce
      • Electronic Gaming
      • Financial Technology
      • Mobile Entertainment
      • Multimedia & Internet
      • Peripherals
      • Social Media
      • STEM (Science, Tech, Engineering, Math)
      • Supply Chain/Logistics
      • Wireless Communications
      • View All Consumer Technology

      • Energy & Natural Resources

      • Alternative Energies
      • Chemical
      • Electrical Utilities
      • Gas
      • General Manufacturing
      • Mining
      • Mining & Metals
      • Oil & Energy
      • Oil and Gas Discoveries
      • Utilities
      • Water Utilities
      • View All Energy & Natural Resources

      • Environ­ment

      • Conservation & Recycling
      • Environmental Issues
      • Environmental Policy
      • Environmental Products & Services
      • Green Technology
      • Natural Disasters
      • View All Environ­ment

      • Heavy Industry & Manufacturing

      • Aerospace & Defense
      • Agriculture
      • Chemical
      • Construction & Building
      • General Manufacturing
      • HVAC (Heating, Ventilation and Air-Conditioning)
      • Machinery
      • Machine Tools, Metalworking and Metallurgy
      • Mining
      • Mining & Metals
      • Paper, Forest Products & Containers
      • Precious Metals
      • Textiles
      • Tobacco
      • View All Heavy Industry & Manufacturing

      • Telecomm­unications

      • Carriers and Services
      • Mobile Entertainment
      • Networks
      • Peripherals
      • Telecommunications Equipment
      • Telecommunications Industry
      • VoIP (Voice over Internet Protocol)
      • Wireless Communications
      • View All Telecomm­unications

  • Lifestyle & Health
      • Consumer Products & Retail

      • Animals & Pets
      • Beers, Wines and Spirits
      • Beverages
      • Bridal Services
      • Cannabis
      • Cosmetics and Personal Care
      • Fashion
      • Food & Beverages
      • Furniture and Furnishings
      • Home Improvement
      • Household, Consumer & Cosmetics
      • Household Products
      • Jewelry
      • Non-Alcoholic Beverages
      • Office Products
      • Organic Food
      • Product Recalls
      • Restaurants
      • Retail
      • Supermarkets
      • Toys
      • View All Consumer Products & Retail

      • Entertain­ment & Media

      • Advertising
      • Art
      • Books
      • Entertainment
      • Film and Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • View All Entertain­ment & Media

      • Health

      • Biometrics
      • Biotechnology
      • Clinical Trials & Medical Discoveries
      • Dentistry
      • FDA Approval
      • Fitness/Wellness
      • Health Care & Hospitals
      • Health Insurance
      • Infection Control
      • International Medical Approval
      • Medical Equipment
      • Medical Pharmaceuticals
      • Mental Health
      • Pharmaceuticals
      • Supplementary Medicine
      • View All Health

      • Sports

      • General Sports
      • Outdoors, Camping & Hiking
      • Sporting Events
      • Sports Equipment & Accessories
      • View All Sports

      • Travel

      • Amusement Parks and Tourist Attractions
      • Gambling & Casinos
      • Hotels and Resorts
      • Leisure & Tourism
      • Outdoors, Camping & Hiking
      • Passenger Aviation
      • Travel Industry
      • View All Travel

  • Policy & Public Interest
      • Policy & Public Interest

      • Advocacy Group Opinion
      • Animal Welfare
      • Congressional & Presidential Campaigns
      • Corporate Social Responsibility
      • Domestic Policy
      • Economic News, Trends, Analysis
      • Education
      • Environmental
      • European Government
      • FDA Approval
      • Federal and State Legislation
      • Federal Executive Branch & Agency
      • Foreign Policy & International Affairs
      • Homeland Security
      • Labor & Union
      • Legal Issues
      • Natural Disasters
      • Not For Profit
      • Patent Law
      • Public Safety
      • Trade Policy
      • U.S. State Policy
      • View All Policy & Public Interest

  • People & Culture
      • People & Culture

      • Aboriginal, First Nations & Native American
      • African American
      • Asian American
      • Children
      • Diversity, Equity & Inclusion
      • Hispanic
      • Lesbian, Gay & Bisexual
      • Men's Interest
      • People with Disabilities
      • Religion
      • Senior Citizens
      • Veterans
      • Women
      • View All People & Culture

  • Hamburger menu
  • Cision PRWeb provides efficient communication tools to continuously engage with target audiences across multiple online channels
  • Create a Free Account
    • ALL CONTACT INFO
    • Contact Us


      11AM ET Sunday – 8PM ET Friday

  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR
  • News in Focus
    • Browse All News
    • Multimedia Gallery
  • Business & Money
    • Auto & Transportation
    • Business Technology
    • Entertain­ment & Media
    • Financial Services & Investing
    • General Business
  • Science & Tech
    • Consumer Technology
    • Energy & Natural Resources
    • Environ­ment
    • Heavy Industry & Manufacturing
    • Telecomm­unications
  • Lifestyle & Health
    • Consumer Products & Retail
    • Entertain­ment & Media
    • Health
    • Sports
    • Travel
  • Policy & Public Interest
  • People & Culture
    • People & Culture
  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR
  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR
  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR

Caldic and Maolac Partner to Bring Clinically Backed Colostrum Based Innovative Ingredients to the North American Nutrition Market


News provided by

Caldic North America

Feb 19, 2026, 11:45 ET

Share this article

Share toX

Share this article

Share toX


Maolac is a biotech company developing a new class of bio-functional protein ingredients inspired by the composition of human breast milk. Using AI-driven proteomics, Maolac identifies and concentrates highly targeted proteins from bovine colostrum to deliver potent, low-dose solutions for gut health, mobility, recovery, immune balance, and healthy aging. Their ingredients are designed for real-world food and nutrition applications, offering strong stability, neutral taste, and flexible formulation options.

TORONTO, Feb. 19, 2026 /PRNewswire-PRWeb/ -- Caldic, a global solutions provider for the food, nutrition, pharmaceutical, and personal care markets, is pleased to announce a new partnership with Maolac, a deep tech bio-technology company developing a novel class of clinically backed colostrum based innovative ingredients inspired by the natural benefits of human breast-milk. Under this collaboration, Caldic will market and distribute Maolac's portfolio across the North American nutrition sector, with commercial rollout planned for 2026.

Maolac's breakthrough biotechnology uses advanced proteomics and AI to map the functional proteins that drive key health benefits in human breast milk, and subsequently identify and extract structurally similar proteins from bovine colostrum and other natural sources. The result is a novel expansion of colostrum innovation, scientifically designed to be human-aligned, and validated by rigorous research. Current offerings include Maolactin-GI™ for gut comfort and microbiome balance; Maolactin-FMR™ for rapid muscle recovery, joint support, mobility, and longevity; and Super Colostrum™, a next-generation concentrated colostrum ingredient optimized for solubility, neutral sensory performance, and requiring very low usage levels. These solutions deliver strong alignment with leading consumer demand spaces such as gut health, immune function, performance, active aging, and daily recovery, while supporting real-world formulation needs like heat stability, processing tolerance, and flexible application formats.

"Maolac is redefining what functional proteins can do by combining breast-milk-inspired biology with advanced proteomics to create targeted, low-dose nutrition solutions designed for modern functional foods and supplements."

Post this

Joe Agocs, Director of Principal Development, Caldic North America, notes that "Maolac's approach represents a meaningful step forward in functional nutrition. Their proteins are highly targeted, potent at low levels, and grounded in strong scientific data that resonates with today's health-driven consumers. We see tremendous opportunity for brands looking to innovate in capsules, beverages, powders, gummies, and functional foods, and this partnership positions Caldic to help customers bring a new generation of solutions to life."

For Maolac, the partnership aligns with a strategy to scale globally with strong technical and commercial partners. Maya Ashkenazi, Maolac founder and CEO, commented that "Caldic's formulation expertise, application capabilities, and deep industry relationships make them an outstanding partner for our next phase of growth. As we prepare to expand our production capacity, this collaboration ensures that our science-driven protein ingredients will reach innovators across North America who are seeking meaningful, differentiated ways to support consumer health."

By combining Maolac's cutting-edge discovery platform with Caldic's commercial reach, technical application support, and customer-centric approach, the two companies aim to deliver a compelling new ingredient toolkit for formulators working at the intersection of nutrition, performance, and wellness. With demand rising for targeted, efficacious ingredients that support gut health, mobility, immune balance, and healthy aging, the partnership creates a significant opportunity for brands looking to differentiate in an increasingly competitive market.

About Maolac

Maolac is a biotechnology company developing bio-functional protein ingredients for human nutrition, inspired by the proteomic profile of human breast milk. Using advanced AI, proteomics, and targeted extraction technologies, Maolac produces high-performance protein complexes that support gut health, mobility, recovery, immune balance, and healthy aging. For more info about Maolac, click here.

About Caldic

Caldic is a global provider of innovative ingredient solutions, serving customers across food, nutrition, personal care, pharma, and industrial markets. With a combination of technical expertise, application labs, manufacturing capabilities, and a collaborative, customer-first approach, Caldic helps brands bring new product ideas to life. For more information about Caldic, click here.

Media Contact

Zane Hussein, Caldic North America, 1 4168993788, [email protected], Caldic North America

SOURCE Caldic North America

Modal title

Maolac technology supports active lifestyles with next-generation bio-functional proteins designed for human nutrition.
Maolac technology supports active lifestyles with next-generation bio-functional proteins designed for human nutrition.
Maolac technology supports active lifestyles with next-generation bio-functional proteins designed for human nutrition.

Contact PRWeb

  • 11AM ET Sunday – 8PM ET Friday
  • Contact Us

About PRWeb

  • About PRWeb
  • Partners
  • Partnership Programs
  • Editorial Guidelines
  • Resources

Why PRWeb

  • Why PRWeb
  • How It Works
  • Who Uses It
  • Pricing

Accounts

  • Create a Free Account
  • Log in
  • Contact Us

Do not sell or share my personal information:

  • Submit via [email protected] 
  • Call Privacy toll-free: 877-297-8921

Contact Cision

Products

About

My Services
  • All News Releases
  • Online Member Center
  • ProfNet
Cision Distribution Helpline
888-776-0942
  • Legal
  • Site Map
  • RSS
  • Cookie Settings
Copyright © 2025 Cision US Inc.